Related Experiment Video
Updated: May 31, 2026

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
Severe cortisol deficiency associated with reversible growth hormone deficiency in two infants: what is the link?
Rebecca McEachern1, Jacques Drouin, Louise Metherell
1Endocrinology Service and Research Center, Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine and University of Montréal, Montréal, Québec, Canada.
Insights
Congenital hypocortisolism can cause growth hormone deficiency (GHD) in infants. Glucocorticoid replacement is crucial for somatotroph development and resolving GHD, ensuring normal growth and preventing hypoglycemia.
Area of Science:
- Pediatric Endocrinology
- Molecular Genetics
- Metabolic Disorders
Background:
- Infantile hypoglycemia poses life-threatening risks, often linked to congenital deficiencies in cortisol and/or growth hormone (GH).
- Accurate diagnosis and management are critical for infant health outcomes.
Observation:
- Two infants presented with severe hypoglycemia, undetectable cortisol, and low GH levels.
- Growth hormone deficiency (GHD) persisted despite initial cortisol replacement therapy.
Findings:
- Genetic analysis revealed mutations in MRAP and TPIT genes, explaining the cortisol deficiency.
- GH deficiency resolved with prolonged glucocorticoid replacement, indicating its role in somatotroph development.
- GH replacement was successfully withdrawn, and infants experienced normal growth and puberty.
Implications:
- Physiological glucocorticoid levels are essential for infant somatotroph development and function.
- Eucortisolism is necessary for accurate GH secretory capacity assessment.
- GH replacement is vital for maintaining normoglycemia in infants.
- Molecular investigations are powerful tools for diagnosing and guiding treatment in infants with complex endocrine disorders.
Context:
Hypoglycemia is potentially life-threatening, especially in infants, and can be due to congenital cortisol and/or GH deficiency (GHD).
Case Illustration:
Two full-term infants had undetectable cortisol levels, but also low GH levels, at the time of severe hypoglycemia. GHD persisted for several months, even after cortisol replacement.
Methods:
Targeted molecular investigations were performed and revealed homozygous inactivating mutations in MRAP (MIM ID 609196) in patient 1 and in TPIT (MIM ID 604614) in patient 2. Because GHD is not part of the MRAP or TPIT phenotypes, we performed GH stimulation tests. These revealed that GHD had resolved by 8 months (patient 1) and 3 yr (patient 2) of glucocorticoid replacement. GH replacement was therefore stopped, hypoglycemia did not recur, and over the subsequent 10 yr, growth and puberty have proceeded normally.
Conclusions:
1) Physiological glucocorticoid levels appear to be required for the development and function of the somatotrophs during infancy. 2) Eucortisolism, like euthyroidism, is required for the proper evaluation of GH secretory capacity. 3) The metabolic effect of GH replacement is essential for the maintenance of normoglycemia, especially in infants. And 4) targeted molecular investigations are a powerful tool to clarify the diagnosis in severely ill infants and to reevaluate the specific treatment they need.
Related Concept Videos
Cushing Syndrome II: Pathophysiology
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Cushing Syndrome I: Introduction
Nature and Nurture
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
Hypoglycemia and Glucagon